Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175340 | SCV000226811 | pathogenic | not provided | 2012-11-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002513840 | SCV003440901 | pathogenic | Cohen syndrome | 2023-10-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser864*) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with VPS13B-related conditions (PMID: 28041643). ClinVar contains an entry for this variant (Variation ID: 95840). For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV002513840 | SCV004100768 | likely pathogenic | Cohen syndrome | 2023-10-12 | criteria provided, single submitter | clinical testing | Criteria applied: PVS1,PM2_SUP |
NIHR Bioresource Rare Diseases, |
RCV000505106 | SCV000598900 | uncertain significance | Abnormality of the eye | 2015-01-01 | no assertion criteria provided | research |